Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 5Recurrence 2Waldenstrom Macroglobulinemia 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lymphoma 1Leukemia 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

fludarabine phosphate 15Cyclophosphamide 13Whole-Body Irradiation 12Peripheral Blood Stem Cell Transplantation 12Tacrolimus 10Etoposide 10Rituximab 8Mycophenolic Acid 8Methotrexate 6Melphalan 6Cyclosporine 6Busulfan 6Antilymphocyte Serum 6Vorinostat 4Sirolimus 4Prednisone 4Lenalidomide 4Immunohistochemistry 4Gene Expression Profiling 4Carboplatin 4Vincristine 3Microarray Analysis 3Gemcitabine 3Everolimus 3Doxorubicin 3Dexamethasone 3Brentuximab Vedotin 3Alemtuzumab 310-propargyl-10-deazaaminopterin 3thymoglobulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Immunoblastic Lymphadenopathy × WW Domain-Containing Oxidoreductase × Clear all
NCT00481871 2020-01-07

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

Acrotech Biopharma Inc.

Phase 1/2 Completed
119 enrolled 13 charts
LymphoidOther hematologic neoplasm

Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Recurrence, Lymphoma, B-Cell, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡